Developing new guidance for healthcare professionals looking after teenagers and young adults with allergies and/or asthma. It is important that young people learn how to self-manage their allergies and/or asthma. Adolescence can be a challenging time for them and their

The Food Standards Agency (FSA) are inviting those affected or interested in food hypersensitivity to participate in an online survey and share their experiences. Around 2% of adults and 8% of children in the UK have a food hypersensitivity. This

The Anaphylaxis Campaign has received the following updated statement from Mylan regarding the availability of EpiPen. This includes information for patients, prescribers, pharmacists, hospitals and schools. Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, has

The Anaphylaxis Campaign is saddened to learn of the death of Sam Collings, aged 19,  who died at Bolton Hospital on the 4th August 2019. According to media reports, neither Sam or his family had suspected that Sam suffered from

The Anaphylaxis Campaign is delighted to hear about the success of Aimmune Therapeutics, Inc. in the approval of their oral immunotherapy drug, Palforzia, by the US Food and Drug Administration (FDA). This is the first oral immunotherapy drug that has

An editorial in the February edition of Clinical and Experimental Allergy (the official journal of the British Society of Allergy and Clinical Immunology) explores the current statutory guidance on the care of children with medical conditions in schools, and highlights

Biopharmaceutical company DBV Technologies has announced positive results from its Viaskin® Peanut trial into reducing the risk of allergic reaction in children aged 4 to 11. Viaskin is a patch applied directly to the surface of the skin and contains

The Anaphylaxis Campaign has received and has been asked to share the following update from Sacla regarding its recent pesto recall. Update from Sacla: Customer health and safety is always our number one priority. In December, when we became aware that cashew

The Coroner has ended the inquest into the death of Shante Turay-Thomas and has delivered her narrative determination and the Prevention of Future Deaths report. The Anaphylaxis Campaign would like to extend our deepest condolences to the family of Shante,